Similarly, hepatic TLR2, TLR4, and TLR9 signaling has been reported to contribute to the pathogenesis of NASH, with the gut bacterial peptidoglycan, LPS and CpG-containing DNA as the corresponding ligand, respectively59–61. The gene discussed is TLR2; the disease is metabolic dysfunction-associated steatohepatitis.